Drottning Silvias barn- och ungdomssjukhus

Gothenburg SE-41685

3 studies enrolling now · 9 studies all time

What they study most

Alport Syndrome, Duchenne Muscular Dystrophy, Focal Segmental Glomerulosclerosis, Hypertension, Pulmonary, IgA Vasculitis, Immunoglobulin A Nephropathy, Low-grade Glioma, Minimal Change Disease, Mucopolysaccharidosis II, Osteosarcoma, Pediatric Low-grade Glioma, Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma

Studies at this site

• Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases — Recruiting now
• A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II) — Recruiting now
• A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension — Running, not enrolling
• An Extension Study of the Long-Term Safety, Tolerability, and Efficacy of Tividenofusp Alfa (DNL310) in Participants With Mucopolysaccharidosis Type II (MPS II) From Study DNLI-E-0002 or Study DNLI-E-0007 — Enrolling by invitation
• DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2) — Running, not enrolling
• Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD) — Completed
• A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma — Completed
• Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy — Stopped early
• A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular Dystrophy. — Stopped early